HyClone reduced-serum media

Friday, 15 August, 2014 | Supplied by: In Vitro Technologies Pty Ltd


A viable alternative to classical media supplemented with 10% FBS is reduced-serum media formulations. These formulations of classical media types, such as DMEM and RPMI, are nutritionally enhanced using the natural components of serum, including lipids, growth factors and proteins, which allow the use of serum to be reduced as low as 2% depending on cell type. Additionally, the reduced serum content in a user’s media helps to reduce any variability in their cell culture due to variability in serum batches, enabling a more flexible process.

The HyClone range of reduced-serum media, along with the full HyClone portfolio of media, serum, buffers and process supplements, is distributed in Australia by In Vitro Technologies. The company provides full product support for the range including serum batch testing support and media customisation.

Online: www.invitro.com.au
Phone: 03 9771 3700
Related Products

AdipoGen Life Sciences Isthmin-1

AdipoGen Life Sciences' Isthmin-1 (human) ELISA Kit is designed to provide specific...

AdipoGen PLXDC2 (human) ELISA Kit

AdipoGen Life Sciences' PLXDC2 (human) ELISA Kit measures human PLXDC2 with a sensitivity of...

Dojindo Laboratories HilyMax Transfection Reagent

Dojindo Laboratories' HilyMax is a newly developed gene transfection reagent that forms...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd